tailor-made industrial solutions based on natural and modified micro-organisms
Abolis Biotechnologies has raised €35M across 1 funding round from 6 investors, most recently a round in Sep 2024. Based in Evry, France; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-09-12 | Other |
| €35M |
| BOLD ,Clay Capital,DeepTech & Climate Fonds,Evonik Venture Capital GmbH,Icos Capital,LIBERSET |
| View deal → |
